Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title |
Type |
$ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) | Contract | $167,627.92 | Clinical Trial | Christian Bime | Medicine | Kinevant Sciences, Inc. | 10/2020 |
| A Novel Polymeric Valve for Transcatheter Aortic Valve Replacement | Contract | $532,239.00 | Research | Marvin Slepian | UAHS Research | PolyNova Cardiovascular, LLC | 12/2020 |
| A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... | Contract | $100,897.00 | Clinical Trial | Setsuko Chambers | Cancer Center Division | GOG Foundation, Inc. | 08/2020 |
| A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase | Contract | $664,687.53 | Clinical Trial | Hani Babiker | Cancer Center Division | PPD Investigator Services, LLC. | 05/2020 |
| Student Aid for Field Epidemiology Response (SAFER) - Pinal County Intergovernmental Agreement (IGA) | Contract | $299,814.00 | Instruction | Kristen Pogreba Brown | Epidemiology and Biostatistics | Pinal County, Arizona | 09/2020 |
| Behavior Change Smoking Cessation - Arizona Department of Administration | Contract | $45,000.00 | Other Sponsored Activity | Mark Martz | Public Hlth Pract & Trans Rsch | Arizona Department of Administration | 09/2020 |
| Alternative Anticoagulant and Biocompatibility Study & Heparin-Impella Surface Interaction with Heparin-Containing Purge Solutions | Contract | $288,559.00 | Research | Marvin Slepian | UAHS Research | ABIOMED, Inc. | 11/2020 |
| Total Shoulder Arthroplasty Multi-Center Registry | Contract | $603,643.00 | Clinical Trial | Joshua Hustedt | COM Phx Orthopedics | Arthrex, Incorporated | 06/2020 |
| Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) | Contract | $173,290.72 | Clinical Trial | Heather Cassell | Asthma/Airway Disease Rsch Ctr | Pharmaceutical Research Associates | 02/2020 |
| A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept | Contract | $854,975.00 | Clinical Trial | Hani Babiker | Cancer Center Division | AbbVie Incorporated | 10/2020 |
| A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness | Contract | $1,003,039.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Eli Lilly and Company | 09/2020 |
| A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately | Contract | $395,132.40 | Clinical Trial | Sasha Taleban | Medicine | PPD Investigator Services, LLC. | 05/2020 |
| Arizona State Opioid Response II Grant - University of Arizona | Contract | $300,000.00 | Research | Maria Manriquez-Sanchez | COM Phx Obstetrics&Gynecology | Arizona Health Care Cost Containment System | 11/2020 |
| Zephyr Valve Registry (ZEVR) | Contract | $148,825.60 | Clinical Trial | Raed Alalawi | COM Phx Internal Medicine | Pulmonx Corporation | 06/2020 |
| FLowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | Contract | $125,613.76 | Clinical Trial | Christopher Goettl | COM Phx Radiology | Inari Medical | 02/2020 |
| A Phase 2 Randomized Study of Adjuvant Immunotherapy with the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma | Contract | $206,150.52 | Clinical Trial | Montaser Shaheen | Cancer Center Division | PPD Investigator Services, LLC. | 10/2020 |
| Consumer Tools for Understanding Water Quality Contaminants and POU/POE Options | Contract | $49,978.00 | Research | Kelly Reynolds | Community Environment & Policy | Water Quality Research Foundation | 12/2020 |
| A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid | Contract | $503,260.68 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Pharmaceutical Research Associates | 08/2020 |
| Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w | Contract | $17,187.52 | Clinical Trial | Kresimira Milas | Surgery | Bard Peripheral Vascular, Inc. | 05/2020 |
| Assessing the Feasibility of Characterizing the Treatment and Survivorship Outcomes of Racial/Ethnic Minorities with IDD using SEER-Medicare Data | Contract | $7,500.00 | Research | Julie Armin | Family and Community Medicine | University of New Mexico | 11/2020 |
| Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients with Metastatic Breast Cancer w | Contract | $100,897.00 | Clinical Trial | Pavani Chalasani | Cancer Center Division | Phoenix Molecular Designs (Canada) | 02/2020 |
| A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine in Participants Undergoing Surgeries that Include a Bowel Resection or Bowel Transection | Contract | $586,018.76 | Clinical Trial | Bellal Joseph | Surgery | Shionogi Inc | 10/2020 |
| COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) | Contract | $1,222,500.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | University of Michigan | 08/2020 |
| Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer | Contract | $323,394.75 | Clinical Trial | Hani Babiker | Cancer Center Division | Vedanta Biosciences, Inc. | 05/2020 |
| Evaluate the Clinical and Economic Outcomes of Performing PD-L1 Test as an In-Vitro Diagnostic (IVD) Vs. as a Laboratory Developed Test (LDT) to Select Patients with Non-Small Cell Lung Cancer (NSCLC) | Contract | $61,080.00 | Research | Jason Hurwitz | HOPE Center | Ventana Medical Systems, Inc. | 07/2020 |